Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| EC0991002-E | Registry Identifier | NHRI EC0991002-E |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Health Research Institutes, Taiwan | OTHER |
| National Taiwan University | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sarcopenia related mobility dysfunction was a preventable presentation in transitional variation of frailty. However, the definition, associated risk factors, clinical course and outcome of sarcopenia in Taiwanese older adults are still under-clarified and need for further study.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| health subjects; outpatients aged over 65 | The research subjects will be culled from outpatients aged over 65 at NTUH; 1000 Taiwanese subjects aged 20-40 equally divided in both genders will be recruited in order to establish the norm of Taiwanese's skeletal muscle index. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Domestic operation tool of sarcopenia for older adults | Young health adults are recruited for measurement of body composition using bio impedance analysis in order to establish the norm of skeletal muscle index | Baseline |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in body composition during aging | Using anthropometric measurements, and bio impedance analysis, the change in body composition are measured in the recruited older adults | up to 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Compare metabolomics profiles in sarcopenic older adults and non-sarcopenic older adults | Using the blood specimen, the metabolomics platform are set up to explore the new bio markers of sarcopenia in older adults | up to 2 years |
| The prognosis of sarcopenia in the older adults |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Healthy subjects One thousand Taiwanese subjects aged 20-40 will be recruited equally divided in both genders. Exclusion criteria includes (1) morbid obesity (BMI over 35) ; (2) long term use of body composition modified medications, like steroid, medications for endocrine diseases (hyperthyroidism, diabetes) and autoimmune diseases; (3) energy consumption diseases, such as cancer, organ failure; (4) pregnant women.
Patient enrollment The research subjects will be culled from outpatients aged over 65 at NTUH.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ching-Yu Chen, MD | National Tiwan University, College of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Taiwan University Hospital | Taipei | 100 | Taiwan |
Not provided
| ID | Term |
|---|---|
| D000073496 | Frailty |
| D055948 | Sarcopenia |
| ID | Term |
|---|---|
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009133 | Muscular Atrophy |
| D020879 | Neuromuscular Manifestations |
Not provided
Not provided
Not provided
Not provided
Not provided
The adverse health outcomes, including hospitalization, emergency visits, or fall events, are recorded every 3 months in order to examine the prognosis of sarcopenia in the elderly |
| up to 2 years |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
| D001284 | Atrophy |
| D020763 | Pathological Conditions, Anatomical |
| D012816 | Signs and Symptoms |